A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.
Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn – Pharmaceutical Technology
Share this article Deciphera also brings ripretinib, marketed under the brand name Qinlock, to the deal. Credits: ESB Professional/Shutterstock.com Deciphera Pharmaceuticals is set to be